No clinically significant association between CFH and ARMS2 genotypes and response to nutritional supplements: AREDS report number 38
about
Genetics and age-related macular degeneration: a practical review for the clinicianThe Application of Genetic Risk Scores in Age-Related Macular Degeneration: A ReviewManagement of neovascular age-related macular degeneration: current state-of-the-art care for optimizing visual outcomes and therapies in developmentBringing the age-related macular degeneration high-risk allele age-related maculopathy susceptibility 2 into focus with stem cell technology.Zinc supplementation inhibits complement activation in age-related macular degeneration.Genetic testing in persons with age-related macular degeneration and the use of the AREDS supplements: to test or not to test?The 2014 Bowman Lecture-Bowman's and Bruch's: a tale of two membranes during the laser revolution.Complement activation and choriocapillaris loss in early AMD: implications for pathophysiology and therapy.CFH Y402H and ARMS2 A69S Polymorphisms and Oral Supplementation with Docosahexaenoic Acid in Neovascular Age-Related Macular Degeneration Patients: The NAT2 Study.Recent advances in the management of dry age-related macular degeneration: A review.Joint Associations of Diet, Lifestyle, and Genes with Age-Related Macular Degeneration.Increased retinal mtDNA damage in the CFH variant associated with age-related macular degeneration.Nutritional supplements in age-related macular degeneration.Pharmacogenetics and nutritional supplementation in age-related macular degeneration.Complement pathway biomarkers and age-related macular degeneration.Antioxidant vitamin and mineral supplements for slowing the progression of age-related macular degeneration.Drusen maculopathy: a risk factor for visual deterioration.Nutrition, Genes, and Age-Related Macular Degeneration: What Have We Learned from the Trials?Benefits, Potential Harms, and Optimal Use of Nutritional Supplementation for Preventing Progression of Age-Related Macular Degeneration.Genetics of age-related macular degeneration (AMD).Precursors of age-related macular degeneration: associations with vitamin A and interaction with CFHY402H in the Inter99 Eye Study.Enhanced Detection of Sub-Retinal Pigment Epithelial Cell Layer Deposits in Human and Murine Tissue: Imaging Zinc as a Biomarker for Age-Related Macular Degeneration (An American Ophthalmological Society Thesis).CFH and ARMS2 genetic risk determines progression to neovascular age-related macular degeneration after antioxidant and zinc supplementation.Genetic Polymorphisms of CFH and ARMS2 Do Not Predict Response to Antioxidants and Zinc in Patients with Age-Related Macular Degeneration: Independent Statistical Evaluations of Data from the Age-Related Eye Disease Study.Genetics and genetic testing for age-related macular degeneration.Response to AREDS supplements according to genetic factors: survival analysis approach using the eye as the unit of analysis.Exploring the Use of Molecular Biomarkers for Precision Medicine in Age-Related Macular Degeneration.A Deep Phenotype Association Study Reveals Specific Phenotype Associations with Genetic Variants in Age-related Macular Degeneration: Age-Related Eye Disease Study 2 (AREDS2) Report No. 14.Macular pigment and serum zeaxanthin levels with Goji berry supplement in early age-related macular degeneration.Complement System and Age-Related Macular Degeneration: Implications of Gene-Environment Interaction for Preventive and Personalized Medicine
P2860
Q26738526-C32A7B33-9D8E-4D6E-AD18-2A793800F6FBQ26766721-4E45F9B7-9B91-4F85-938A-1C8D2B7A3AD6Q26824335-4AE01ABC-AF24-4E48-9E40-30EC8FD2DDA3Q33768195-C85FC09C-8833-450D-9798-30AA026FA7ACQ34506404-120AF1CF-74B6-4B24-9F35-060333170750Q34778837-743E43B7-EC85-4657-B3F4-98D4AD8D68FDQ34905251-94B290D9-6D91-4778-84F2-9C556FF730AAQ35118257-9925A494-C393-47A6-839C-091F2EE676F7Q35679791-1C2101F3-563B-4B9A-B33B-92A601597E00Q36377333-2DE92A1C-3AFD-4748-B7A2-931AAA83129AQ36468066-E06EF9CB-CFCC-4C16-AE80-3603BF968891Q36828352-B97E2CF5-C692-4254-8DAF-58CE40754812Q38317289-313A6848-2AF3-48AF-90EE-9707518F7414Q38510019-7276C7CD-B7CC-4432-9D4C-EE57F093981FQ38614012-B4D5BBC5-F37A-46B5-A243-70C6CEEE2EC1Q38653249-191A2DB2-F23E-4D6F-B56D-CB67C0C27340Q38786743-20938706-5351-44C6-8CC8-1FFB801B34EAQ38800270-64963B48-C258-466A-94E4-A57F72AC6728Q39014462-35452513-8216-4424-8DAA-07F7B8229DDEQ40064848-40AF0580-C808-4B22-90D2-0BEF1D2EAF6CQ40396176-D1BCE835-B9DE-4FB9-9111-8EE5BFD28A33Q42261791-AF2F166A-5728-4C12-8D5E-796194F5F7AAQ47567166-70416100-C161-4962-BB6F-FD1101B089E6Q47793048-3DE44373-5090-4C57-A021-1690AB2FF0DDQ48326680-32CEA602-7D7F-4275-A621-D307137ADE11Q51608120-33A2378A-0456-4294-90B5-A7B8AE0DF9ACQ52559837-74A9EDB0-1FC2-484A-AAC0-B3A5483AB7B2Q52818918-8E3AEFDB-3C7D-4911-9559-74222EAEFF46Q55491304-6D166F76-2B29-4265-BF10-9B81DC575394Q58702202-114C1FE5-4F45-4654-9116-15376591A430
P2860
No clinically significant association between CFH and ARMS2 genotypes and response to nutritional supplements: AREDS report number 38
description
2014 nî lūn-bûn
@nan
2014 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
No clinically significant asso ...... ements: AREDS report number 38
@ast
No clinically significant asso ...... ements: AREDS report number 38
@en
No clinically significant asso ...... ements: AREDS report number 38
@nl
type
label
No clinically significant asso ...... ements: AREDS report number 38
@ast
No clinically significant asso ...... ements: AREDS report number 38
@en
No clinically significant asso ...... ements: AREDS report number 38
@nl
prefLabel
No clinically significant asso ...... ements: AREDS report number 38
@ast
No clinically significant asso ...... ements: AREDS report number 38
@en
No clinically significant asso ...... ements: AREDS report number 38
@nl
P2093
P2860
P50
P1433
P1476
No clinically significant asso ...... ements: AREDS report number 38
@en
P2093
Albert O Edwards
Gonçalo R Abecasis
Michael L Klein
Traci E Clemons
P2860
P304
P356
10.1016/J.OPHTHA.2014.05.008
P50
P577
2014-06-26T00:00:00Z